MMI Funding

Funding

• 2026-10-08 - Series D - $125M - MMI raises $125 million Series D for Symani commercial expansion - BioStar Capital led the financing, with new investors S3 Ventures and Angelini Ventures joining an undisclosed strategic corporate investor and existing backers. - source: globenewswire.com
• 2026-09-16 - Strategic co-investment - $19.6M - MMI receives €17M EIB–Angelini Ventures co-investment - Medical Microinstruments received a new €17M co-investment from the European Investment Bank and Angelini Ventures to support its microsurgery robotics business. - source: angeliniventures.com
• 2024-02-21 - Series C - $110M - MMI completes Series C financing led by Fidelity - MMI completed Series C financing led by Fidelity Management & Research Company to expand Symani commercialization and clinical evidence. - source: mmimicro.com
• 2022-07-20 - Series B - $75M - MMI completes Series B financing for Symani commercialization - MMI completed Series B financing led by Deerfield Management to expand Symani commercialization and clinical development. - source: mmimicro.com